A cannabinoid with cardiovascular activity but no overt behavioral effects

@article{Adams2005ACW,
  title={A cannabinoid with cardiovascular activity but no overt behavioral effects},
  author={M. Adams and J. Earnhardt and B. R. Martin and L. Harris and W. Dewey and R. Razdan},
  journal={Experientia},
  year={2005},
  volume={33},
  pages={1204-1205}
}
Abnormal-Δ8-tetrahydrocannabidiol (ABN-Δ8-THC) failed to elicit central nervous system and cardiovascular effects in laboratory animals. Abnormal-cannabidiol (ABN-CBD) was also devoid of overt behavioral effects but produced marked hypotension with only slight bradycardia in anesthesized dogs. 
31 Citations
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
  • 220
  • Highly Influenced
Blood pressure regulation by endocannabinoids and their receptors
  • 77
  • PDF
Cardiovascular pharmacology of cannabinoids.
  • 119
  • PDF
Anandamide-Mediated CB1/CB2 Cannabinoid Receptor-Independent Nitric Oxide Production in Rabbit Aortic Endothelial Cells
  • 47
Evidence for novel cannabinoid receptors.
  • 397
Lovinger Evidence for novel cannabinoid receptors
  • Highly Influenced
  • PDF
...
1
2
3
4
...

References

SHOWING 1-9 OF 9 REFERENCES
Marihuana-like activity of new synthetic tetrahydrocannabinols
  • 21
Pharmacology of some Marijuana Constituents and Two Heterocyclic Analogues
  • 55
An intravenous formulation of Δ9‐tetrahydrocannabinol using a non‐ionic surfactant
  • 35